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Background: The annual incidence of tennis elbow in the general population is high (1–3%). Tennis elbow
often leads to limitation of activities of daily living and work absenteeism. Physiotherapy and braces are
the most common treatments.
Objectives: The hypothesis of the trial was that no difference exists in the cost effectiveness of
physiotherapy, braces, and a combination of the two for treatment of tennis elbow.
Methods: The trial was designed as a randomised controlled trial with intention to treat analysis. A total of
180 patients with tennis elbow were randomised to brace only (n = 68), physiotherapy (n = 56), or a
combination of the two (n = 56). Outcome measures were success rate, severity of complaints, pain,
functional disability, and quality of life. Follow up was at six, 26, and 52 weeks. Direct healthcare and
non-healthcare costs and indirect costs were measured. Mean cost differences over 12 months were
evaluated by applying non-parametric bootstrap techniques.
Results: No clinically relevant or statistically significant differences were found between the groups. Success
rate at 12 months was 89% in the physiotherapy group, 86% in the brace group, and 87% in the combination
group. Mean total costs per patient were J2069 in the brace only group, J978 in the physiotherapy group,
andJ1256 in the combination group. The mean difference in total costs between the physiotherapy and brace
group was substantial (J1005), although not significant. Cost effectiveness ratios and cost utility ratios showed
physiotherapy to be the most cost effective, although this also was not statistically significant.
Conclusion: No clinically relevant or statistically significant differences in costs were identified between the
three strategies.
T
ennis elbow, or lateral epicondylitis, is characterised by
pain on the lateral side of the elbow, which is aggravated
by resisted dorsal flexion of the wrist.1 2 It is a common
complaint, with an estimated annual incidence in the general
population of 1–3%.3 4 The natural history of tennis elbow is
relatively mild: untreated, the complaints are estimated to
last between six months and two years, and few patients
need an operation.2 5 6
The pain experienced results in absence from work in
about 16% of patients in Dutch general practice, with a mean
sick leave of 9.3 weeks.7
Several treatment options are available,8 9 including a wait
and see policy, corticosteroid injections, orthotic devices,
surgery, and several physiotherapeutic modalities. In the
Netherlands, 28% of patients with tennis elbow are referred
to a physiotherapist, and in 21% of the patients a brace is
prescribed.8–10
Recent systematic reviews on the effectiveness of phy-
siotherapy,11 corticosteroid injections,12 and orthotic devices
such as braces13 all conclude that, currently, insufficient
evidence is available, with most trials being small and of
insufficiently methodological quality. In addition, almost
none of the trials has included a cost effectiveness analysis
that also included indirect costs such as sick leave.
Because of the lack of evidence and the mild natural
course, a wait and see policy is advised.1 14 It is uncertain,
however, if application of a brace in this approach is cost
effective. Very limited evidence is available that confirms the
wait and see policy. As no treatment strategy has yet been
shown to be superior, we conducted a trial comparing the
effectiveness and cost of commonly used interventions for
tennis elbow, to give direction to the search for the optimal
treatment.
Cost effectiveness analyses are important in current
medical practice, as cost is nowadays often a decisive factor
in whether an intervention is to be implemented.
METHODS
Setting
The trial was performed in the Netherlands between January
1999 and May 2001. Patients were recruited for inclusion by
general practitioners and physiotherapists and referred to a
research outpatient clinic. The hospital’s medical ethics
committee approved the study.
Patients
Patients were included if they had elbow complaints for at
least six weeks and clinically diagnosed lateral epicondylitis:
pain on the lateral side of the elbow, which aggravated with
both pressure on the lateral epicondyle of the humerus and
resisted dorsiflexion of the wrist. Exclusion criteria were
bilateral complaints, a clear decrease in pain in the preceding
two weeks, any form of treatment for the lateral epicondylitis
episode in the six months before inclusion, and inability to
fill out questionnaires.
Study design
Baseline assessments were performed by a medical doctor
(GMMJ Kerkhoffs) before randomisation. They included
patient characteristics, comorbidity, and baseline values of
the outcome measures.
After providing written informed consent, patients were
included in the trial. Randomisation was performed by a
blinded researcher (PS), using a computer program with a
minimisation strategy for duration of complaints—that is,
(3 months, 3–6 months, and >6 months.15 16
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Treatment strategies
Patients in the physiotherapy group were treated according to
a standardised protocol (available on request from the first
author). During the six week intervention period, patients
received nine sessions, consisting of three, two, one, one, one,
and one session(s) a week. Every session consisted of
7.5 minutes of pulsed ultrasound treatment according to
the protocol of Binder et al.17 In addition, patients were
treated by friction massage for 5–10 minutes. When the pain
subsided, patients were instructed in a strengthening and
stretching protocol (available on request from the first
author) to perform at home twice a day.18 A standard
treatment lasted 30 minutes.
Patients in the brace group were provided with the brace
(Epipoint; Bauerfeind, Zeulenroda, Germany; fig 1) immedi-
ately after randomisation. They were instructed in its
application and use by a researcher (PS) using a standardised
protocol (available on request from the first author). They
were asked to visit a participating physiotherapist once
during the first week of the intervention period. The
physiotherapist again instructed the patient according to
the standardised protocol. Patients were advised to wear the
brace continuously during the day throughout the interven-
tion period. Activities that caused pain despite the use of the
brace were discouraged.
Patients in the combination group received both the brace
and physiotherapy.
Outcome assessment
Outcomes were assessed by the blinded assessor (GMMJ
Kerkhoffs) at six weeks and one year after randomisation.
Main outcome measures were as follows.
N Global measure of improvement on a six point scale (1,
completely recovered; 2, much improved; 3, little
improved; 4, not changed; 5, a little worse; 6, much
worse).19 20 This measure was dichotomised: patients who
reported being completely recovered or much improved
were considered a success
N Severity of the patient’s complaints (11 point scale: 0, no
complaints; 10, serious complaints)
N Pain intensity of the patient’s most serious complaint (11
point scale: 0, no pain; 10, severe pain)
N Quality of life, assessed using the EuroQol21 and expressed
as utility22
Economic evaluation
The main objective of the economic evaluation was to assess
cost effectiveness and cost utility of brace only, physiother-
apy, and the combination of brace and physiotherapy for
patients with tennis elbow. It was performed from a societal
perspective, so that direct healthcare, direct non-healthcare,
and indirect costs were used as economic indicators (table 1).
Firstly, relevant categories of resource utilisation were
identified. Secondly, the volume of each category was
measured and multiplied by the resource costs. Resource
utilisation was collected using standard forms for phy-
siotherapists and questionnaires filled out by patients at
six, 26 and 52 weeks follow up.
The direct healthcare and non-healthcare costs were
estimated according to the Dutch guidelines for cost analysis
in healthcare research.23 When these guidelines were not
applicable, the tariffs of the Dutch Central Organisation for
Health Care Charges were used to estimate the costs. Visits to
other healthcare professionals—for example, acupunctur-
ists—were estimated on the basis of prices recommended by
their professional organisations. Drug costs were estimated
using prices recommended by the Royal Dutch Society for
Pharmacy.24 The time a patient spent visiting a practitioner
was also included in cost calculations, using a shadow price
of J7.94 per hour.
Indirect costs of production losses were calculated for both
paid and unpaid labour. For paid labour, these costs were
calculated using the friction cost approach.25 26 The basic
concept of the friction cost approach is that the amount of
production loss (and/or costs of maintaining production)
because of sick leave depends on the time span needed to
restore the initial level of production and costs. Sick
employees can be replaced after a necessary period of
adaptation, the friction period, which was estimated to be
122 days in the Netherlands.23 For unpaid labour, the indirect
costs were estimated using a shadow price of J7.94 per hour.
Statistical analysis
An intention to treat analysis was used in the economic
evaluation. Fewer than 5% of the data were missing. Therefore
missing costs were replaced by the mean of the measured costs
based on previous data for the patient at issue.
To compare costs between groups, bootstrapping was used
for pair-wise comparison of the mean differences in direct
healthcare, direct non-healthcare, indirect, and total costs
between the three interventions. Confidence intervals were
obtained by bias corrected and accelerated bootstrapping,
choosing 500 for the number of replications.27
The cost effectiveness and cost utility ratios were also
calculated with bootstrapping (5000 replications) according
to the bias corrected percentile method by using clinical
Figure 1 Brace used in treatment of tennis elbow.
Table 1 Costs used in the economic evaluation
Cost (J)*
General practitioner (maximum session of 20 minutes) 16.59
Physiotherapist (maximum session of 30 minutes) 18.15
Outpatient care, medical specialist 40.84
Hospital stay per day 170.17
Professional home care (per hour) 22.70`
Acupuncture (first consultation) 93.35
Acupuncture (subsequent consultation) 46.70
Chiropractor (per session) 34.03
Help from partner/friends (per hour) 7.94
Absenteeism from paid labour (per hour) Variable
Absenteeism from unpaid labour (per hour) 7.94
*J1 = US$1.26 (February 2004).
Surgical treatment of tennis elbow as a procedure in day care.
`Mean cost of professional home care in this study population.
Prices according to the Dutch Association for Acupuncture and
Netherlands Chiropractic Association.
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outcomes.28 The bootstrapped cost-effect pairs were graphi-
cally represented on a cost effectiveness plane (fig 2).
Acceptability curves were calculated, which show the
probability that a treatment is cost effective at a specific
ceiling ratio (fig 3).29 30
The differences in improvement between the groups with
corresponding 95% confidence interval (95% CI) were com-
puted and compared using one way analysis of variance.
Logistic regression was used to analyse dichotomous outcomes.
Subgroup analyses were performed for:
(1) cost of sick leave based on a patient’s true salary versus
mean income of the Dutch population by age and sex;
(2) the influence of the intensity of labour (light/heavy) on
work absenteeism.
Analysis 1 was performed to identify the influence of true
income on the outcome of costs compared with the mean
income of the Dutch population. A few patients with a high
income can have an enormous influence on the cost of sick
leave and thus on the cost effectiveness of a certain
treatment. The second analysis was performed hypothesising
that patients in jobs involving heavy labour are likely to be on
sick leave for a longer period because performing such jobs
with elbow pain is unlikely to be satisfactory for either the
patient or the employer. The subdivision of light/heavy labour
was made on the basis of whether lifting was a major part of
the paid employment. This subdivision was made for each
patient separately in a consensus group meeting with three
authors. Statistical methods for the subgroup analyses were
identical with those used for the whole group of patients.
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Figure 2 Example of a cost effectiveness plan comparing the effect of the combination treatment and physiotherapy for pain on the main complaint.
No advantageous effects or costs for either treatment (equal distribution of cost-effect pairs in all quadrants) were shown.20
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Figure 3 Acceptability curve for combination treatment and physiotherapy for pain on main complaint.
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RESULTS
In total, 180 patients were included in the trial and
subsequently randomised to physiotherapy (n = 56), brace
only treatment (n = 68), or the combination treatment (n =
56). At the one year follow up, complete cost data were available
for 168 (93%) patients, 63 (93%) from the brace only group, 52
(93%) in the physiotherapy group, and 53 (95%) in the
combination group. The baseline characteristics were well
matched for all intervention groups (table 2). No significant
differences in possible prognostic factors were identified.
Clinical effects
Table 3 gives the clinical effects. At the one year follow up,
neither clinically relevant nor significant differences were
identified (reported in more detail elsewhere7) on any of the
primary outcome measures.
Utilisation of healthcare resources and work
absenteeism
Table 4 presents information on utilisation of healthcare
resources and work absenteeism. Visits to a general practi-
tioner were minimal in all groups. As expected, the number
of visits to a physiotherapist was highest in the physiotherapy
and combination groups. The standardised programme
consisted of nine sessions, but patients in both groups were
additionally treated, adding up to a total mean number of
treatment sessions of 11.8 and 13.6 sessions respectively. In
the brace only group, the number of visits was substantial:
after six weeks of brace only treatment, patients received
additional physiotherapy treatment for a mean of 4.9
sessions. Patients in the brace only group received more
professional home care as well as help from partner or friends
compared with the physiotherapy and combination groups.
At the start of the trial, 42 (75%) patients in the
physiotherapy group were employed, 55 (81%) patients in
the brace only group, and 43 (77%) patients in the
combination group. Sick leave was taken by four patients
(4/42; 9%) in the physiotherapy group, 12 patients (12/55;
22%) in the brace only group, and seven patients (7/43; 16%)
in the combination group. Over all groups, 16% of the
patients reported taking sick leave for a mean period of
9.3 weeks.
Absenteeism from unpaid work was also higher in the
brace only group: mean (SD) 42.6 (119.9) hours compared
with 15.7 (41.8) hours in the physiotherapy, and 6.7
(17.0) hours in the combination group. This difference was,
however, not significant.
One patient from the brace group had day-care surgical
treatment in hospital. Medication was prescribed for two
patients in the physiotherapy group and one in the
combination group. An additional five patients bought drugs
over the counter: two in the brace only group and three in the
combination group.
Direct costs
Direct healthcare costs were significantly higher in the
combination group than in the brace only and physiotherapy
groups (table 5), mainly because of costs incurred during the
intervention period.
Direct non-healthcare costs were significantly higher in the
brace only group when compared with the physiotherapy
group, but not compared with the combination group.
Mean (SD) total direct costs were J417 (386) in the
physiotherapy group, J564 (1173) in the brace only group,
and J518 (802) in the combination group. The difference is
not significant.
Table 2 Baseline characteristics
Physiotherapy
(n = 56)
Brace
(n = 68)
Combination
(n = 56)
Age (years) 43 (8) 46 (11) 47 (9)
Duration of complaints (weeks) 16 (16) 23 (30) 21 (37)
Male (%) 48 53 50
Dominant arm affected (%) 77 74 71
Neck/shoulder complaints (%) 18 25 18
Primary outcome measures
Severity of complaints* 44 (18) 47 (19) 48 (17)
Pain most important complaint* 72 (20) 74 (18) 72 (15)
Pain-free function questionnaire 48 (16) 51 (17) 52 (16)
Utility (EuroQol)` 0.74 (0.19) 0.68 (0.25) 0.68 (0.28)
Unless otherwise indicated, values are mean (SD).
*Rated on numerical rating scales (0–10) and transformed into scores ranging from 0 to 100: 0, no complaints;
100, serious complaints.
Questionnaire scores were 0–40; scores were transformed into scores of 0–100: 0, no complaints; 100, serious
complaints.
` EuroQol score ranged from 0 to 1: 0, death; 1, perfect health.
Table 3 Results at one year follow up (mean improvement since baseline) for each intervention group in patients with tennis
elbow with mean differences between groups
Physiotherapy
(A) (n = 56)
Brace
(B) (n = 68)
Combination
(C) (n = 56)
Mean differences in improvement (95% CI)
A–B A–C B–C
Success (%) 89 (47) 86 (54) 87 (47) 4 (27 to 17) 3 (28 to 16) 21 (214 to 12)
Severity of complaints 28 (19) 31 (20) 32 (21) 23 (210 to 5) 24 (211 to 4) 21 (28 to 6)
Pain most important complaint 60 (27) 60 (28) 58 (27) 0 (210 to 11) 2 (28 to 13) 2 (28 to 12)
Pain Free Function Questionnaire` 37 (16) 40 (18) 42 (20) 23 (29 to 3) 25 (212 to 1) 22 (29 to 5)
Utilities (EuroQol) 0.12 (0.16) 0.17 (0.29) 0.18 (0.30) 0.04 (20.2 to 0.1) 0.05 (20.2 to 0.1) 0.01 (20.1 to 0.1)
Success was measured as the percentage of patients who recovered.
Values are mean (SD). Rated on numerical rating scales (0–10) and transformed into scores ranging from 0 to 100: 0, no complaints; 100, serious complaints .
`Values are mean (SD). Questionnaire scores are 0–40, and were transformed into scores of 0–100: 0, no complaints; 100, serious complaints.
Values are mean (SD). Score on EuroQol ranging from 0 (death) to 1 (perfect health).
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Indirect costs
Indirect costs were significantly higher in the brace only
group than in the physiotherapy group (table 5). Costs in the
brace only group were J1416 (2890) compared with J557
(1851) in the physiotherapy group (mean difference J859
(95% CI 174 to 1870)). No significant differences in indirect
costs were present either between physiotherapy and
combination treatment or between brace only and combina-
tion treatment.
Total costs
Total costs were J975 (1989) in the physiotherapy group,
J1980 (3673) in the brace only group, and J1258 (2403) in
the combination group (table 5). The difference in total costs
between physiotherapy and brace only treatment was J1005
(95% CI 234 to 1964).
Cost effectiveness ratios and cost uti lity ratios
For brace only versus physiotherapy, the cost effectiveness
ratios for outcome measures success rate, severity of
complaint, and pain for the most serious complaint differed
significantly, all favouring physiotherapy (table 6).
Comparing brace only and combination treatment, statis-
tically significant ratios were found for success rate, pain for
most important complaint, and score on EuroQol, all
favouring combination treatment.
Comparing cost effectiveness ratios for physiotherapy and
combination treatment, no significant differences were
identified. On the cost effectiveness plane (fig 2), cost-effect
pairs are equally distributed in all quadrants, suggesting that
physiotherapy and the combination treatment do not differ
in either cost or effect.
Sensitivity analyses
The mean true income in this trial was similar for the brace only
(J159 net a week) group and the combination group (J158). In
the physiotherapy group, it was somewhat higher: J208.
Using the Friction costs method, mean sick leave costs
were J1081 for the brace only group, J436 for the
physiotherapy group, and J621 for the combination group.
Using the mean income for all patients, these sick leave costs
were comparable: J921 for the brace only, J341 for the
physiotherapy, and J439 for the combination group.
Using this true mean income, sick leave costs were J758
for the brace only group, J277 for the physiotherapy group,
and J259 for the combination group. Thus, with the true
income method, the combination treatment turns out to be
the least costly intervention, whereas if the other two
methods are used, the physiotherapy treatment is the least
costly.
The results of this sensitivity analysis did not lead to
different conclusions.
In the brace only group, 55 patients (81%) had jobs during
the trial, of which 32 (58%) were light jobs and 23 (42%)
were heavy labouring jobs. In the light labour group, five
patients (16%) reported a mean of 64 days sick leave. In the
heavy labour group, seven patients (30%) reported a mean of
68 days sick leave.
In the physiotherapy group, 42 patients (75%) had jobs
during the trial, of which 28 were light jobs and 14 were
heavy labouring. In the light labour group, one patient (4%)
reported a mean sick leave of 125 days. In the heavy labour
group, three patients (21%) reported a mean sick leave of
39 days.
In the combination group, 43 patients (77%) had jobs
during the trial, of which 23 were light labour jobs and 20
were heavy labour jobs. In the light labour group, two
patients (9%) reported a mean sick leave of 91 days. In the
heavy labour group, five patients (25%) reported a mean sick
leave of 26 days.
Neither of these two sensitivity analyses led to different
conclusions from those resulting from the primary analysis.
DISCUSSION
At the one year follow up, no clinically relevant or statistically
significant differences in effectiveness were found between
the three intervention groups. Therefore cost may be a
decisive factor in deciding which treatment is to be preferred
for tennis elbow. Although the mean total costs in the
physiotherapy group were J1005 lower than in the brace only
Table 4 Type of utilisation of healthcare resources and work absenteeism per
intervention group during 52 weeks
Healthcare resource (unit of measurement)
Physiotherapy
(n = 56)
Brace
(n = 68)
Combination
(n = 56)
General practice (no of visits) 0.10 (0.4) 0.09 (0.4) 0.2 (0.6)
Physiotherapy (no of treatment sessions) 11.8 (7.4) 4.9 (11.0) 13.6 (8.8)
Medical specialist (no of treatment sessions) 0.04 (0.3) 0.06 (0.3) 0.02 (0.1)
Professional home care (no of hours) 1.4 (7.6) 7.0 (33.9) 0 (0)
Alternative health care (no of visits) 0.09 (0.7) 0.2 (1.3) 0.05 (0.4)
Help from partner/friends (no of hours) 1.4 (35.6) 30.3 (96.7) 5.9 (16.3)
Absenteeism from paid labour (no of days) 4.3 (19.6) 11.7 (32.4) 5.6 (19.3)
Absenteeism from unpaid labour (no of hours) 15.7 (41.8) 42.6 (119.9) 6.7 (17.0)
Values are mean (SD).
Table 5 Bootstrap of the mean (SD) difference in costs in euros over a one year period for patients with tennis elbow treated
with physiotherapy, brace, or a combination of the two
Physiotherapy
(A) (n = 56)
Brace
(B) (n = 68)
Combination
(C) (n = 56)
Mean difference (95% confidence interval)
A–B B–C A–C
Direct healthcare cost total 237 (149) 190 (342) 309 (225) 247 (2116 to 70) 2119 (2214 to 218) 272 (2153 to 217)
Direct non-healthcare cost total 179 (298) 374 (1042) 204 (613) 195 (8 to 574) 170 (279 to 517) 225 (2271:94)
Direct cost total 417 (386) 564 (1173) 518 (802) 2147 (2502 to 68) 46 (2316 to 392) 2101 (2504 to 46)
Indirect cost total 557 (1851) 1416 (2890) 739 (2072) 2859 (21870 to 2174) 677 (2234 to 1539) 2182 (21035 to 463)
Total costs 975 (1989) 1980 (3673) 1258 (2403) 21005 (2964 to 34) 722 (2474 to 1838) 2283 (21378 to 407)
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group, this difference was not significant. One could argue that
our study lacked power to find a statistically significant relevant
difference in costs. Indeed, the sample size calculation was
based on identifying a relevant difference in clinical effects and
not in costs. The sample size necessary to detect a difference of
J1000 would have been 120 patients per group.31
Baseline characteristics were comparable for all interven-
tion groups. Differences were not significant and are there-
fore unlikely to influence the overall treatment effect of the
treatment strategies studied.
The direct healthcare costs in the physiotherapy and
combination group were significantly higher than in the
brace only group. This difference was mainly the result of the
greater number of physiotherapy sessions in the intervention
period. The indirect costs were highest in the brace group.
This may suggest that the direct costs of physiotherapy may
be worth while because the results imply that physiotherapy
is associated with an earlier return to work and less
absenteeism. This is, however, hypothetical and cannot be
stated for certain based on the results of this trial.
The cost effectiveness ratios showed physiotherapy to be
superior to the use of a brace on three out of four outcome
measures. This suggests that physiotherapy should be the
preferred treatment. However, the confidence intervals are so
large that it should be questioned whether this conclusion
can definitively be drawn. The same can be said for cost
effectiveness ratios for comparison of brace and combination
treatment.
A recent study evaluating physiotherapy, corticosteroid
injections, and a wait and see policy for tennis elbow showed
similar costs for the physiotherapy group.32 In our trial, the total
costs in this group were J975, and the costs in the trial
described by Korthals-de Bos et al. were J921. On the basis of
these two trials, a wait and see policy and physiotherapy seem
to be the most efficient treatment options for tennis elbow.
To summarise, because in our trial none of the treatments
were clinically superior at the long term follow up, the
treatment that costs least should be the preferred initial
treatment. Physiotherapy cost considerably less than the
brace only treatment, although the difference was not
significant. As no significant differences were identified in
either effect or cost, we cannot suggest a preferred interven-
tion from the results of this trial.
Some clinical questions were not addressed in our trial.
Future research should focus on patients whose complaints
have not resolved after a wait and see policy. Which
treatment is best for these non-responders should further
be studied. In addition, more studies should focus on the
speed of recovery and identification of subgroups that may
favour certain specific interventions (and the diagnostic tools
to diagnose these).
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. . . . . . . . . . . . . . COMMENTARY . . . . . . . . . . . . . .
More than 40 treatments for tennis elbow have been
described in the literature, but it is the wait and see policy
recommended by general practitioners in the Netherlands
that is currently most often discussed. It has stirred up a lot
of emotion in the sports medicine world all around the globe
and will be the topic of discussion at the next tennis medical
conference at Roland Garros, Paris, in June 2006. This study
adds an interesting element to the discussion by not only
calculating the direct healthcare costs, but also the indirect
costs. Also, the authors draw attention to the fact that a
solution needs to be found for patients who do not respond to
the wait and see policy. With the recent positive publications
on eccentric training for Achilles tendon and patellar tendon
problems, I look forward to a trial comparing the effective-
ness of eccentric training with a wait and see policy for tennis
elbow. And I definitely look forward to the discussions at
Roland Garros!
B M Pluim
Royal Netherlands Lawn Tennis Association, Amersfoort, the
Netherlands; bpluim@euronet.nl
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